The transcesarean intrauterine device
Guitrón Cantu, A.; Muñoz Pérez, M.; Martínez Elizondo, G.A.; Forsbach, G.; González Martínez, M.D.
Ginecologia y Obstetricia de Mexico 56: 162-165
1988
ISSN/ISBN: 0300-9041 PMID: 3154233 Document Number: 377424
Document emailed within 1 workday
Related Documents
Munteanu, O.; Cirstoiu, M.; Antoniac, I.; Cirstoiu, C. 2016: Comparison of Pain Level During and After Intrauterine Device Insertion: Levonorgestrel-Releasing Intrauterine System Versus the Copper T Intrauterine Device Environmental Engineering and Management Journal 15(5): 965-972Andolsek, L.; Teeter, R.A.; Kozuh Novak, M.; Wheeler, R.; Fortney, J.A.; Rosenberg, M.J. 1986: Time to conception after intrauterine device removal importance of duration of use intrauterine device type pelvic inflammatory disease and age International Journal of Gynecology and Obstetrics 24(3): 217-224
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Ozgu-Erdinc, A.S.; Tasdemir, U.G.; Uygur, D.; Aktulay, A.; Tasdemir, N.; Gulerman, H.C. 2014: Outcome of intrauterine pregnancies with intrauterine device in place and effects of device location on prognosis Contraception 89(5): 426-430
Blumenthal, P.D.; Goldthwaite, L.M. 2015: Intrauterine Device Insertion During Cesarean Delivery: the Rising Tide of the Postdelivery Intrauterine Device Obstetrics and Gynecology 126(1): 1-2
Roy, S.; Azen, C. 1994: A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: A paradigm for assessing intrauterine contraceptive device safety American Journal of Obstetrics and Gynecology 170(6): 1606
Wang, K.; Cheng, Y.; Yang, H.; Tang, Y.H.; Jiang, J.; Ji, F.; Li, L.B.; Wu, S.C. 2016: Effectiveness research of medicated γ intrauterine device and medicated genefix intrauterine device inserted immediately after abortion Zhonghua Fu Chan Ke Za Zhi 51(3): 198-203
Archer, D.F.; Desoto, K.R.; Baker, J.M. 1999: Interleukin-6 and tumor necrosis factor-α concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone : A possible mechanism of action of the intrauterine device Contraception (Stoneham) 59(3): 175-179
Archer, D.F.; DeSoto, K.R.; Baker, J.M. 1999: Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone. a possible mechanism of action of the intrauterine device Contraception 59(3): 175-179
2009: Dispositifs intra-utérins, alias stérilets : Deuxième partie : Connaître les détails pratiques de la pose d'un dispositif intra-utérin - Intrauterine contraceptive device : Part 2 : Know the practical details of the installation of an intrauterine device la Revue Prescrire 29(305): 202-206
2009: Dispositifs intra-utérins, alias stérilets : Deuxième partie : Connaître les détails pratiques de la pose d'un dispositif intra-utérin - Intrauterine contraceptive device : Part 2 : Know the practical details of the installation of an intrauterine device la Revue Prescrire 29(305): 202-206
Yang, Q.; Tian, X.K.; Chau, X.J. 1991: Relationship between intrauterine device and intrauterine pressure and levels of PGs in uterine fluid Sheng Zhi Yu Bi Yun 11(4): 39-45
Bilgehan, F.; Dilbaz, B.; Karadag, B.; Deveci, C.D. 2015: Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception Journal of Obstetrics and Gynaecology Research 41(9): 1426-1432
Davies, A.; Fleming, C. 2014: Do intrauterine device/intrauterine system users check their threads? Journal of Family Planning and Reproductive Health Care 40(2): 122-125
Bosco-Lévy, P.; Gouverneur, A.; Langlade, C.; Miremont, G.; Pariente, A. 2019: Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study Contraception 99(6): 345-349
Akintomide, H.; James, A.; Moffat, M.; Barnes, P.; Rankin, J. 2022: Systematic review of copper intrauterine contraception continuation in young nulliparous women based on intrauterine device type Bmj Open 12(10): E060606
Akintomide, H.; James, A.; Moffat, M.; Barnes, P.; Rankin, J. 2022: Systematic review of copper intrauterine contraception continuation in young nulliparous women based on intrauterine device type Bmj Open 12(10): E060606
Salma, U.; Xue, M.; Md Sayed, A.S.; Xu, D. 2014: Efficacy of intrauterine device in the treatment of intrauterine adhesions Biomed Research International 2014: 589296